 |
Video: What is a Stock Split?
|
 |
| Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis. It specializes in the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its CNM-Au8 is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the nicotinamide adenine dinucleotide pathway while reducing oxidative stress. According to our CLNN split history records, Clene has had 1 split. | |
 |

Clene (CLNN) has 1 split in our CLNN split history database. The split for CLNN took place on July 11, 2024. This was a 1 for 20 reverse split, meaning for each 20 shares of CLNN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as Clene conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CLNN split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Clene shares, starting with a $10,000 purchase of CLNN, presented on a split-history-adjusted basis factoring in the complete CLNN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/19/2018 |
|
| End date: |
11/18/2025 |
|
| Start price/share: |
$195.00 |
|
| End price/share: |
$8.56 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.61% |
|
| Average Annual Total Return: |
-35.66% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$439.11 |
|
| Years: |
7.09 |
|
|
 |
| Date |
Ratio |
| 07/11/2024 | 1 for 20 |
|
 |